Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)
Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocular pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool for optimizing surgical outcomes. Non-ophthalmic formulations of bromfenac were withdrawn in the US in 1998 due to cases of severe liver toxicity.[L43942,T239]
For the treatment of postoperative inflammation in patients who have undergone cataract extraction.
Categories
Agents causing hyperkalemiaAnalgesicsAnalgesics, Non-NarcoticAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)Antirheumatic AgentsBenzene DerivativesCentral Nervous System AgentsCyclooxygenase InhibitorsHydrocarbons, BrominatedHydrocarbons, HalogenatedKetonesNephrotoxic agentsOphthalmologicalsPeripheral Nervous System AgentsSelective Cyclooxygenase 2 Inhibitors (NSAIDs)Sensory OrgansSensory System Agents
ATC-Code
S01BC11
CAS number
91714-94-2
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682